SEC Filing Update: #SABS SAB Biotherapeutics, Inc. : $3.78

Sector: Healthcare | YTD: 🔼+ 0.80% The SEC disclosed Today (10-AUG-2026) that RA CAPITAL MANAGEMENT has INCREASED #SABS Shares by 118.33% 🟢 * Previous Holdings: 4.40M Shares * Current Holdings: 9.61M Shares * Increase+5.21M * Increased(%)+118.33% * Ownership: 9.9% * Estimated Investment Value: $19.27M https://www.thinksabio.com/reports/isr/SABS Institutional ownership in #SABS has been steadily rising over the past 4 quarters in Shares: Q2 2025: 1.92M Q3 2025: 28.02M Q4 2025: 36.34M Q1 2026: 69.19M